drugset / Trial / NCT02206048

Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix

NCT02206048

Completed 9 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelDiagnostic

Summary

The goal of this clinical research study is to learn if it is possible to get high-resolution microendoscopy (HRME) images of AIS tissue and/or tissue from microinvasive carcinoma right before a biopsy of the cervix. Researchers also want to learn if HRME images can show the difference between cancerous tissue and normal cervical tissue.

Timeline

Start
2015-10-02
Primary completion
2021-04-21
Completion
2021-04-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Proflavine Diagnostic / imaging agent 0.01 % Topical

Indications